Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001752026-24-000002
Filing Date
2024-12-26
Accepted
2024-12-23 17:34:58
Documents
1
Effectiveness Date
2024-12-26
Items
Item 06b:
Item 4a5:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 8013
  Complete submission text file 0001752026-24-000002.txt   9127
Mailing Address 30 WASHINGTON AVENUE, SUITE F HADDONFIELD NJ 08033
Business Address 30 WASHINGTON AVENUE, SUITE F HADDONFIELD NJ 08033 856-433-1500
Linnaeus Therapeutics, Inc. (Filer) CIK: 0001752026 (see all company filings)

EIN.: 474846130 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-521284 | Film No.: 241575081